A Systems Approach to Designing Effective Clinical Trials Using Simulations
Author(s) -
Vincent A. Fusaro,
Prasad Patil,
Chih-Lin Chi,
Charles F. Contant,
Peter J. Tonellato
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.123034
Subject(s) - dosing , medicine , pharmacogenetics , clinical trial , clinical study design , warfarin , protocol (science) , population , pharmacodynamics , intensive care medicine , medical physics , pharmacokinetics , pharmacology , alternative medicine , chemistry , environmental health , genotype , gene , atrial fibrillation , biochemistry , pathology
Pharmacogenetics in warfarin clinical trials have failed to show a significant benefit in comparison with standard clinical therapy. This study demonstrates a computational framework to systematically evaluate preclinical trial design of target population, pharmacogenetic algorithms, and dosing protocols to optimize primary outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom